Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cartilage extracellular matrix (ECM) is a highly specialized, dense network of macromolecules that provides the structural and functional foundation for cartilage tissue. It constitutes over 90% of the volume in articular cartilage, with chondrocytes—the primary cell type—making up less than 10%. The ECM is essential for maintaining tissue integrity, enabling load-bearing functions, and supporting joint movement. It is composed mainly of type II collagen fibers interwoven with aggrecan-rich proteoglycans and organized into distinct zones around chondrocytes affecting both structure and signaling roles. Degradation or abnormal remodeling leads to loss of function seen in degenerative diseases such as osteoarthritis.
Modulation of ECM remodeling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cartilage Extracellular Matrix (ECM).